Fabry Disease in India
How patients in India access treatment for fabry disease via Named Patient Program.
About Fabry Disease
Metabolic
Treatment access in India
India's CDSCO permits import of unapproved drugs under Rule 36 for personal use by patients with a prescription from a registered medical practitioner. Named Patient import is common for rare-disease indications.
For patients in India with fabry disease whose required therapy is not locally registered, a Named Patient Program pathway typically applies.
How Reserve Meds supports patients with fabry disease in India
- Patient or physician contacts us with disease details and therapy requested.
- We verify eligibility in India and confirm US supply.
- Treating physician in India issues prescription and justification.
- We file India-specific NPP/personal-import paperwork.
- We source the drug from a DSCSA-compliant US specialty wholesaler.
- Cold-chain shipment to the patient's physician or hospital pharmacy in India.
Patient support throughout
- Case manager from request through delivery.
- Documentation translation where needed.
- Physician-to-physician support for clinical justification.
- Re-supply coordination for chronic therapy.